Scarica l'app Stockscreener
2.60
4.84%
0.12
Dopo l'orario di chiusura:
2.60
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Holdings Boosted by Bank of America Corp DE - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of “Buy” from Analysts - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street Zen - Defense World
Black Diamond’s 2025 Annual Stockholders Meeting Highlights - TipRanks
Black Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant Upside - Seeking Alpha
Wellington Management Group LLP Grows Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Squarepoint Ops LLC Buys 72,688 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded to Hold Rating by Wall Street Zen - Defense World
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Nuveen Asset Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Northern Trust Corp - Defense World
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewswire
17,317 Shares in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Bought by D. E. Shaw & Co. Inc. - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) & Fresh Tracks Therapeutics (NASDAQ:FRTX) Critical Comparison - Defense World
Brokerages Set Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Price Target at $14.60 - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at Wall Street Zen - Defense World
Black Diamond Therapeutics Reports Strong Q1 2025 Earnings - TipRanks
3 Promising Penny Stocks With Market Caps Under $200M - Yahoo Finance
Price T Rowe Associates Inc. MD Cuts Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wedbush Issues Optimistic Estimate for BDTX Earnings - Defense World
Dimensional Fund Advisors LP Has $1.42 Million Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Raymond James Financial Inc. Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Stifel Financial Corp Raises Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wells Fargo & Company MN Buys 5,932 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Inc (BDTX) Q1 2025 Earnings: Net Inco - GuruFocus
Black Diamond (BDTX) Strengthens Financial Position with Robust Cash Reserves | BDTX Stock News - GuruFocus
Black Diamond Therapeutics (BDTX) Surpasses Q1 Earnings Expectat - GuruFocus
What You Didn’t Know About Black Diamond Therapeutics Inc (NASDAQ: BDTX) This Week - Stocksregister
Hsbc Holdings PLC Has $59,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Barclays PLC Increases Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Reports Q1 2025 Financial Results and Updates on Clinical Trials for BDTX-1535 - Nasdaq
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Skill-Knowledge-Conduct - TradingView
JPMorgan Chase & Co. Has $41,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Market Momentum: Black Diamond Therapeutics Inc (BDTX) Registers a -12.28 Decrease, Closing at 1.47 - DWinneX
BlackRock, Inc. Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus
Black Diamond Therapeutics Inc expected to post earnings of 20 cents a shareEarnings Preview - TradingView
Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year - Yahoo Finance
A History of Outperforming Analyst Forecasts and Beating the Odds: Black Diamond Therapeutics Inc (BDTX) - Sete News
Black Diamond Therapeutics Inc (BDTX) stock analysis: A comprehensive overview - uspostnews.com
Black Diamond Therapeutics Inc’s Banking’s 100-Day Moving Average at 2.0161: Will the Stock Break Through? - investchronicle.com
Geode Capital Management LLC Has $2.05 Million Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Financial Metrics Exploration: Understanding Black Diamond Therapeutics Inc (BDTX) Through Ratios - DWinneX
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Bought by Renaissance Technologies LLC - The AM Reporter
Black Diamond Therapeutics Inc (BDTX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Wellington Management Group LLP - Defense World
Raymond James Financial Inc. Purchases New Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX Stock Sees Decline of Approximately -12.66% in Last Five Days - knoxdaily.com
Black Diamond stock hits 52-week low at $1.42 amid challenges - Investing.com India
Black Diamond stock hits 52-week low at $1.42 amid challenges By Investing.com - Investing.com South Africa
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):